Regulatory product record
IMMITICIDE
Product identity, ingredients and source provenance from the regulatory catalogue. Linked clinical evidence has a separate review status.
Product identity
- Brand name
- IMMITICIDE
- DIN
- 02242073
- DPD drug code
- 65746
- Regulatory category
- APPROVED_VET_DRUG
- Market status
- MARKETED
- Route(s)
- INTRAMUSCULAR
- Pharmaceutical form(s)
- POWDER FOR SOLUTION
- Ingredients
- MELARSOMINE DIHYDROCHLORIDE (50 MG)
- Species (DPD record)
- DOGS
- Company
- BOEHRINGER INGELHEIM ANIMAL HEALTH CANADA INC. (DIN owner)
Source and provenance
- Source dataset
- health_canada_dpd_marketed
- Source snapshot date
- Not available in this source
- Source record key
- 65746
- Archive fingerprint (SHA-256)
- 85cc3ce208af3aa57018c3d14d83f90220c436baef7455384b6d48d9774e1c88
Linked clinical reference
Clinical entries are linked through the active molecule. Check their species, formulation, source and review status separately from this product record.
Clinical evidence
Dose regimens0
No dose regimens recorded for this species selection.
Adverse effects114
These are counts of spontaneously reported events, not proven adverse effects, causal relationships, or incidence rates.
Bars compare report counts within each species; they do not show incidence.
More reportsFewer reportsDog
- INEFFECTIVE, HEARTWORM ADULTS3,883 reports
- Vomiting2,596 reports
- Lack of efficacy (endoparasite) - heartworm2,382 reports
- Injection site swelling2,216 reports
- Injection site pain1,378 reports
- Pain NOS1,236 reports
- Anorexia1,185 reports
- Diarrhoea1,133 reports
- Depression1,082 reports
- Lethargy (see also Central nervous system depression in 'Neurological')1,015 reports
- Fever964 reports
- Death922 reports
Cat
- Death5 reports
- Accidental exposure3 reports
- Depression2 reports
- Respiratory distress2 reports
- Vocalisation2 reports
- Cardiorespiratory arrest1 reports
- Diarrhoea1 reports
- Drug administration error1 reports
- Dyspnoea1 reports
- Heavy breathing1 reports
- Lung oedema1 reports
- Polypnoea1 reports
Literature references14
References are linked to this drug. Species applicability is not recorded here, so the species filter does not narrow this list. Imported dates do not retain their original precision; confirm dates in the original citation.
- Non-Arsenical heartworm adulticidal therapy using topical moxidectin-imidacloprid and doxycycline: A prospective case series.
Study summary not available in the imported record. Open the original citation to review the study.
- Use of Slow-Release Injectable Moxidectin for Treatment of Dirofilaria immitis Infection During Pregnancy.
Study summary not available in the imported record. Open the original citation to review the study.
- Efficacy of imidacloprid 10%/moxidectin 2.5% spot on (Advocate®, Advantage Multi®) and doxycycline for the treatment of natural Dirofilaria immitis infections in dogs.
Study summary not available in the imported record. Open the original citation to review the study.
- Variation of the adulticide protocol for the treatment of canine heartworm infection: Can it be shorter?
Study summary not available in the imported record. Open the original citation to review the study.
- Safety and efficacy of three trypanocides in confirmed field cases of trypanosomiasis in working equines in The Gambia: a prospective, randomised, non-inferiority trial.
Study summary not available in the imported record. Open the original citation to review the study.
Sources: PubMed, National Library of Medicine; openFDA, U.S. Food and Drug Administration.